Glenmark Pushes Back On US Price-Fixing Charges

DoJ Allegations Filed Against Firm Include Pravastatin Collusion With Apotex

Glenmark has issued a forceful rebuttal over US price-fixing charges being pursued by the country’s Department of Justice covering drugs such as pravastatin.

Glenmark_Magnified
Glenmark is under DoJ scrutiny over generic price-fixing • Source: Shutterstock

Glenmark has issued a forceful rebuttal pushing back against US price-fixing charges that have just been filed by the country’s Department of Justice.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Legal & IP

More from Generics Bulletin